Patents by Inventor Min Jung Kang

Min Jung Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250016019
    Abstract: A server for managing a home appliance and a method for controlling the same are disclosed. The disclosed server and control method therefor can obtain current information on a specific administrative division regarding a residential space, and compare the acquired current weather information on the specific administrative division with environmental information detected in a home appliance so as to predict in advance an operational error of the home appliance. Accordingly, it is possible to accurately predict an operational error of the home appliance that may occur in the further, and to prevent an operational error in advance.
    Type: Application
    Filed: March 25, 2022
    Publication date: January 9, 2025
    Inventors: Chiwan PARK, Hoonsang YUN, Daegeun SEO, Min Jung KANG
  • Patent number: 12186408
    Abstract: The present invention provides fusion polypeptides for inhibiting angiogenesis, fusion protein nanocages having peptides for inhibiting angiogenesis, and diagnostic and therapeutic (theranostic) uses thereof.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: January 7, 2025
    Assignee: Industry-University Cooperation Foundation Hanyang University Erica Campus
    Inventors: Dong Woo Lim, Min Jung Kang
  • Publication number: 20240372127
    Abstract: An electrode assembly includes two separators, at least one first electrode plate between the two separators, the at least one first electrode plate being aligned with the two separators into a zigzag shape, and second electrode plates coupled to the zigzag shape opposite to the at least one first electrode plate, the second electrode plate being outside of the two separators.
    Type: Application
    Filed: April 10, 2024
    Publication date: November 7, 2024
    Inventor: Min Jung Kang
  • Patent number: 11866470
    Abstract: Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly]n or a [Val-Pro-Ala-Xaa-Gly]n (SEQ ID NO:2) pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: January 9, 2024
    Assignee: Industry-University Cooperation Foundation Hanyang University Erica Campus
    Inventors: Dong Woo Lim, Jae Sang Lee, Min Jung Kang
  • Patent number: 11827679
    Abstract: The present disclosure relates to a self-assembled nanostructure of an elastin- and resilin-based block copolypeptide with stimuli responsiveness and resilience for drug delivery, tissue engineering and regenerative medicine, a method for preparing the same and application thereof. The diblock polypeptide reversibly forms a self-assembled micelle structure in response to temperature stimuli and a hydrogel prepared using the triblock polypeptide undergoes reversible sol-gel or gel-sol transition in response to temperature stimuli and exhibits enhanced mechanical strength due to chemical crosslinkages between tyrosine residues. With such superior properties, the diblock/triblock polypeptide of the present disclosure can be used for drug delivery systems, scaffolds for tissue engineering and kits for tissue or organ regeneration.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: November 28, 2023
    Assignee: Industry-University Cooperation Foundation Hanyang University Erica Campus
    Inventors: Dong Woo Lim, Aamna Basheer, Jae Sang Lee, Min Jung Kang
  • Patent number: 11518798
    Abstract: Disclosed is a fusion polypeptide for inhibiting neovascularization, including a peptide specifically binding to vascular endothelial growth factor (VEGF) receptors, and a hydrophilic elastin-based polypeptide (hydrophilic EBP) linked to the peptide.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: December 6, 2022
    Assignees: Industry-University Cooperation Foundation Hanyang University Erica Campus, Inje University Industry-Academic Cooperation Foundation
    Inventors: Dong Woo Lim, Min Jung Kang, Jae Sang Lee, Sae-Gwang Park
  • Publication number: 20220331453
    Abstract: The present invention provides fusion polypeptides for inhibiting angiogenesis, fusion protein nanocages having peptides for inhibiting angiogenesis, and diagnostic and therapeutic (theranostic) uses thereof.
    Type: Application
    Filed: April 17, 2020
    Publication date: October 20, 2022
    Inventors: Dong Woo LIM, Min Jung KANG
  • Patent number: 11408886
    Abstract: Provided are a method of screening for novel therapeutic targets to develop therapeutic agents for colon cancer, and prognostic biomarkers for colon cancer treatment which are screened using the same.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: August 9, 2022
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Min-Jung Kang, Byung Hwa Jung, Young Sook Yoo, Thanh Binh Nguyen
  • Publication number: 20210388042
    Abstract: Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly]n or a [Val-Pro-Ala-Xaa-Gly]n (SEQ ID NO:2) pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.
    Type: Application
    Filed: June 8, 2021
    Publication date: December 16, 2021
    Applicant: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
    Inventors: Dong Woo LIM, Jae Sang LEE, Min Jung KANG
  • Patent number: 11059870
    Abstract: Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly (SEQ ID NO: 1) pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly (SEQ ID NO: 2) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly (SEQ ID NO: 1)]n or a [Val-Pro-Ala-Xaa-Gly (SEQ ID NO: 1)]n pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: July 13, 2021
    Assignee: Industry-University Cooperation Foundation Hanyang University Erica Campus
    Inventors: Dong Woo Lim, Jae Sang Lee, Min Jung Kang
  • Publication number: 20200354416
    Abstract: The present disclosure relates to a self-assembled nanostructure of an elastin- and resilin-based block copolypeptide with stimuli responsiveness and resilience for drug delivery, tissue engineering and regenerative medicine, a method for preparing the same and application thereof. The diblock polypeptide reversibly forms a self-assembled micelle structure in response to temperature stimuli and a hydrogel prepared using the triblock polypeptide undergoes reversible sol-gel or gel-sol transition in response to temperature stimuli and exhibits enhanced mechanical strength due to chemical crosslinkages between tyrosine residues. With such superior properties, the diblock/triblock polypeptide of the present disclosure can be used for drug delivery systems, scaffolds for tissue engineering and kits for tissue or organ regeneration.
    Type: Application
    Filed: March 23, 2017
    Publication date: November 12, 2020
    Applicant: Industry-University Cooperation Foundation Hanyang University Erica Campus
    Inventors: Dong Woo LIM, Aamna BASHEER, Jae Sang LEE, Min Jung KANG
  • Publication number: 20200331986
    Abstract: Disclosed is a fusion polypeptide for inhibiting neovascularization, including a peptide specifically binding to vascular endothelial growth factor (VEGF) receptors, and a hydrophilic elastin-based polypeptide (hydrophilic EBP) linked to the peptide.
    Type: Application
    Filed: April 20, 2020
    Publication date: October 22, 2020
    Applicants: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS, INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Dong Woo LIM, Min Jung KANG, Jae Sang LEE, Sae-Gwang PARK
  • Publication number: 20200270317
    Abstract: Disclosed is a polypeptide having a phase transition behavior, wherein the polypeptide consists of a Val-Pro-Gly-Xaa-Gly (SEQ ID NO: 1) pentapeptide repeat or a Val-Pro-Ala-Xaa-Gly (SEQ ID NO: 2) pentapeptide repeat, and the polypeptide includes a [Val-Pro-Gly-Xaa-Gly (SEQ ID NO: 1)]n or a [Val-Pro-Ala-Xaa-Gly (SEQ ID NO: 1)]n pentapeptide repeat. In addition, the present invention provides a multi-stimuli polypeptide composed of polypeptide-calmodulin-polypeptide having a phase transition behavior and a hydrogel prepared using the same. A dynamic protein hydrogel according to the present invention may be used as a drug carrier, as a scaffold for tissue engineering or as a kit for tissue or organ regeneration.
    Type: Application
    Filed: April 7, 2016
    Publication date: August 27, 2020
    Applicant: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
    Inventors: Dong Woo LIM, Jae Sang LEE, Min Jung KANG
  • Patent number: 10662236
    Abstract: Disclosed is a fusion polypeptide for inhibiting neovascularization, including a peptide specifically binding to vascular endothelial growth factor (VEGF) receptors, and a hydrophilic elastin-based polypeptide (hydrophilic EBP) linked to the peptide.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: May 26, 2020
    Assignees: Industry-University Cooperation Foundation Hanyang University Erica Campus, Inje University Industry-Academic Cooperation Foundation
    Inventors: Dong Woo Lim, Min Jung Kang, Jae Sang Lee, Sae-Gwang Park
  • Publication number: 20190369101
    Abstract: Provided are a method of screening for novel therapeutic targets to develop therapeutic agents for colon cancer, and prognostic biomarkers for colon cancer treatment which are screened using the same.
    Type: Application
    Filed: May 31, 2019
    Publication date: December 5, 2019
    Inventors: Min-Jung KANG, Byung Hwa JUNG, Young Sook YOO, Thanh Binh NGUYEN
  • Patent number: 10266568
    Abstract: Rheumatoid arthritis is efficiently diagnosed with improved patient's convenience using a rheumatoid arthritis diagnosis composition and a kit, each including cyclic citrullinated peptide (CCP), a rheumatoid arthritis diagnosis method using the CCP, the rheumatoid arthritis diagnosis composition, or the kit, a method of obtaining information for rheumatoid arthritis diagnosis, and a method of screening a novel diagnostic marker for rheumatoid arthritis.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: April 23, 2019
    Assignee: Korea Institute of Science and Technology
    Inventors: Min Park, Min-Jung Kang, Byung Hwa Jung, Young Sook Yoo
  • Patent number: 10216046
    Abstract: A liquid crystal display device is provided. A liquid crystal display device comprising: a first substrate and a second substrate opposed to the first substrate; a liquid crystal layer interposed between the first substrate and the second substrate; a lower layer disposed on the first substrate and including at least one contact hole; and a spacer portion disposed on the lower layer, wherein the spacer portion includes a main spacer not overlapping the contact hole and an auxiliary spacer overlapping at least a portion of the contact hole, and a distance between the main spacer and the second substrate is smaller than a distance between the auxiliary spacer and the second substrate.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: February 26, 2019
    Assignee: Samsung Display Co., Ltd.
    Inventors: Nu Ree Um, Min Jung Kang, Hee Ra Kim, Sang Hun Lee
  • Publication number: 20180208642
    Abstract: Disclosed is a fusion polypeptide for inhibiting neovascularization, including a peptide specifically binding to vascular endothelial growth factor (VEGF) receptors, and a hydrophilic elastin-based polypeptide (hydrophilic EBP) linked to the peptide.
    Type: Application
    Filed: October 19, 2016
    Publication date: July 26, 2018
    Applicants: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS, INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Dong Woo LIM, Min Jung KANG, Jae Sang LEE, Sae-Gwang PARK
  • Patent number: 9891487
    Abstract: An array substrate for a display device includes a first substrate which includes a display region and a non-display region enclosing a periphery of the display region, a second substrate facing the first substrate which includes the display region and the non-display region enclosing a periphery of the display region, a color filter disposed on the first substrate, a liquid crystal layer disposed on the color filter and a black matrix disposed on the first substrate in the non-display region and at least a part of the display region, where the black matrix has a thickness ranging from about 2.5 micrometers to about 6.0 micrometers.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: February 13, 2018
    Assignee: SAMSUNG DISPLAY CO. LTD.
    Inventors: Dae Youn Park, Sang Hun Lee, Min Jung Kang, Chang Hun Kwak
  • Patent number: 9664942
    Abstract: Provided is a liquid crystal display, including a first substrate including a plurality of pixel regions including a transmissive light area and a non-transmissive light area, a second substrate facing the first substrate and a liquid crystal layer disposed between the first substrate and the second substrate, wherein the pixel regions includes color filters disposed on a base substrate, a pixel electrode disposed on each of the color filters at the transmissive light area and a black column spacer at a region except a region corresponding to the transmissive light area, wherein the each of the color filters has substantially rectangular shape with a long side and a short side, and wherein the long side has a recess portion in which a part of a long side corresponding to the non-transmissive light area is removed.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: May 30, 2017
    Assignee: Samsung Display Co., Ltd.
    Inventors: Dae Youn Park, Sang Hun Lee, Min Jung Kang, Chang Hun Kwak, Young Bong Cho